Aesther Healthcare (AEHA) Secures $60M Backstop for Ocean Biomedical Deal
by Marlena Haddad on 2023-02-10 at 4:08pm

Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA) announced this afternoon that it has entered into an amended $60 million OTC equity prepaid forward transaction with Vellar Opportunity Fund.

The backstop agreement comes a week after Aesther shareholders approved its combination with biotech firm Ocean Biomedical at a special meeting held on February 3, but the parties have not yet closed the deal. As a refresher, the SPAC already secured a $40 million backstop with Meteora Capital Partners back in October and another $40 million from Vellar at its deal announcement.

Pursuant to today’s agreement, Vellar has agreed to support the transaction by purchasing up to 6,000,000 shares of Aesther Class A common stock for up to $60 million, including from other stockholders that chose to redeem and subsequently revoked their elections. The SPAC has agreed to purchase those shares from Vellar on a forward basis and the purchase price will include a prepayment in the amount of the redemption price per share.

The backstop agreement matures on the earlier to occur of 3 years after the deal closes or the date specified by Vellar in a written notice delivered if the VWAP during 30 out of 45 consecutive trading days is less than $4 per share.

In addition, Vellar will receive $12,408,000 from the trust, which will be used to purchase share consideration shares that otherwise would have been redeemed. These shares, however, are not subject to the backstop agreement. Aesther has the option to repurchase the share consideration shares from Vellar for $3 million at any time during the first six months after the prepayment date.

If the VWAP price of AEHA is equal to or above $20.00 per share for any 30 trading days during a 45 consecutive trading day-period and the aggregate trading volume in respect of such shares during the same 20-day period is at least the product of  three and the difference of the number of shares and the terminated shares, then Aesther can notify Vellar to cause the maturity date to occur.

Additionally, the backstop agreement calls for the adjustment of the reset price on the first scheduled trading day of each month starting on the first calendar month following the closing of the deal to be the lowest of the then-current reset price, the initial price and the VWAP price of the shares of the last ten trading days of the prior calendar month, but not lower than $10.34.

The reset price may be reduced further in connection with a dilutive offering undertaken by Aesther. This would entitle Aesther to terminate the backstop agreement early and require Vellar to pay an amount equal to the product of the number of shares Aesther elects to terminate from the transaction and the reset price as of the termination date.

At maturity, any remaining shares will be purchased by Aesther at maturity for an additional $2.50 per share. During the term of the agreement, Vellar may sell the shares subject to the agreement after which those shares will no longer be subject to the agreement. In this case, Vellar will repay the SPAC with a portion of the sale proceeds.

If the backstop agreement is terminated after the business combination fails to close, then Aesther will be obligated to pay Vellar a fee of $1 million along with certain fees and expenses.

Aesther Healthcare announced its $345 million combination with Ocean Biomedical on August 31, 2022. Providence, Rhode Island-based Ocean Biomedical is developing treatments for malaria and different cancer types.

Recent Posts
by Kristi Marvin on 2025-04-28 at 5:29pm

Digital Asset Acquisition Corp. (NASDAQ:DAAQU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DAAQU”, Tuesday, April 29, 2025. The new SPAC aims to combine with a target company in the digital asset and cryptocurrency sectors. Digital Asset Acquisition Corp.’s management team...

by Nicholas Alan Clayton on 2025-04-28 at 5:13pm

Real Asset Acquisition Corp. (NASDAQ:RAAQU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “RAAQU”, Tuesday, April 29, 2025. The new SPAC aims to combine with a target company in the quantum computing, metals/mining, rare earth and infrastructure sectors. Real Asset Acquisition Corp.’s...

by Nicholas Alan Clayton on 2025-04-28 at 4:17pm

Kochav Defense Acquisition Corp. (NASDAQ:KCHVU) has filed for a $220 million SPAC to bring Israeli defense sector experience to a hunt for a target in that growing business sphere. The new SPAC is not over-funded and offers one right to a 1/7 share in each unit. It will have 18 months to initially close a deal,...

by Nicholas Alan Clayton on 2025-04-28 at 12:22pm

Columbus Circle I (NASDAQ:CCCMU) has filed for a $200 million SPAC to serve as an in-house SPAC led by underwriter Cohen & Company. The new SPAC is to have 24 months on its initial clock with a  1/2 warrant in each unit and will not over-fund its trust, instead including $10.00 per unit in the account...

by Nicholas Alan Clayton on 2025-04-28 at 8:25am

At the SPAC of Dawn This week is set to be busy for SPACs at both ends of their processes as four SPACs are seeking to price their IPOs in the first two days of the week while six SPACs that are already trading have scheduled votes clustered on Wednesday and Friday. Distoken (NASDAQ:DIST) and...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved